Codes / ICD10CM / M1A.242

M1A.242 Drug-induced chronic gout, left hand

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Drug-Induced Chronic Gout, Left Hand

Summary

Drug-induced chronic gout, left hand is a form of arthritis affecting the left hand joints, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and may involve the formation of tophi (urate crystal deposits) in advanced stages.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the left hand joints and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

  • Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
  • Prolonged exposure to urate-raising drugs
  • Pre-existing hyperuricemia or gout history
  • Renal impairment affecting drug clearance

Symptoms

  • Recurrent episodes of intense left hand joint pain, often with swelling and redness
  • Persistent warmth and tenderness in the affected left hand joints
  • Formation of tophi (hard, painless lumps) around the left hand joints
  • Stiffness and limited range of motion in the left hand
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging studies to confirm urate crystal deposition. Blood tests assess uric acid levels, while joint fluid analysis or ultrasound may identify crystal presence. The left-hand involvement is documented to align with the specific code.

Treatment Options

Treatment focuses on reducing uric acid levels and managing symptoms. Medications may include urate-lowering agents (e.g., allopurinol) and anti-inflammatories for flare-ups. Lifestyle modifications, such as dietary changes, may complement pharmacologic therapy. Joint-specific interventions address pain or tophi if present.

Prognosis and Follow-Up

Prognosis depends on early intervention and adherence to treatment. Chronic management aims to prevent further joint damage and tophi formation. Regular follow-up monitors uric acid levels and adjusts therapy to maintain control, reducing long-term complications.

Complications

Untreated or poorly managed cases may lead to joint deformity, chronic pain, or functional impairment. Tophi can erode bone or surrounding tissues, and recurrent inflammation increases the risk of secondary infections or arthritis progression.

Lifestyle & Prevention

Limiting alcohol and purine-rich foods may help reduce flare-ups. Staying hydrated supports uric acid excretion. Avoiding or adjusting medications that raise uric acid levels, when possible, under medical guidance, can prevent exacerbation.

When to Seek Professional Help

Seek care for persistent left hand pain, swelling, or stiffness unresponsive to home measures. Immediate attention is needed for severe symptoms, fever, or signs of infection, which may indicate complications requiring urgent intervention.

Tips for Medical Coders

Document the left-hand involvement and chronic nature of the condition. Specify if tophi are present or absent, as this may impact code specificity. Ensure medication history and uric acid levels are noted to support the drug-induced etiology. Use M1A.242 for this condition.

Book a walkthrough

M1A.242 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.